MPWT
ZYNE

MassMutual Private Wealth & Trust’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed – – 1920
2022
Q4 		$0 Hold
150
– – ﹤0.01% 1902
2022
Q3 		$0 Buy
+150
New +$170 ﹤0.01% 1866

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MassMutual Private Wealth & Trust's ZYNE Position: Q1 2023 in Review

MassMutual Private Wealth & Trust sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2023, closing a stake of 150 shares.

MassMutual Private Wealth & Trust first reported a position in ZYNE in Q3 2022 and held it in 2 quarters. The position peaked at $0 in Q4 2022. 44 funds tracked by Wall St. Rank hold ZYNE as of Q1 2023.

  • MassMutual Private Wealth & Trust reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 150 Zynerba Pharmaceuticals, Inc shares in Q1 2023.
  • MassMutual Private Wealth & Trust first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2022 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's Zynerba Pharmaceuticals, Inc position peaked at $0 in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2023, filed 11 Apr 2023.